HUP0303906A3 - Herbal composition for angina pectoris, method to prepare same and uses thereof - Google Patents

Herbal composition for angina pectoris, method to prepare same and uses thereof

Info

Publication number
HUP0303906A3
HUP0303906A3 HU0303906A HUP0303906A HUP0303906A3 HU P0303906 A3 HUP0303906 A3 HU P0303906A3 HU 0303906 A HU0303906 A HU 0303906A HU P0303906 A HUP0303906 A HU P0303906A HU P0303906 A3 HUP0303906 A3 HU P0303906A3
Authority
HU
Hungary
Prior art keywords
angina pectoris
herbal composition
prepare same
prepare
same
Prior art date
Application number
HU0303906A
Other languages
English (en)
Original Assignee
Cardionat Inc Whitestone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardionat Inc Whitestone filed Critical Cardionat Inc Whitestone
Publication of HUP0303906A2 publication Critical patent/HUP0303906A2/hu
Publication of HUP0303906A3 publication Critical patent/HUP0303906A3/hu

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
    • G01N30/94—Development
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HU0303906A 2000-12-22 2001-12-18 Herbal composition for angina pectoris, method to prepare same and uses thereof HUP0303906A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25805700P 2000-12-22 2000-12-22
PCT/US2001/049396 WO2002058625A2 (en) 2000-12-22 2001-12-18 Herbal composition for angina pectoris, method to prepare same and uses thereof

Publications (2)

Publication Number Publication Date
HUP0303906A2 HUP0303906A2 (hu) 2004-05-28
HUP0303906A3 true HUP0303906A3 (en) 2005-05-30

Family

ID=22978916

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303906A HUP0303906A3 (en) 2000-12-22 2001-12-18 Herbal composition for angina pectoris, method to prepare same and uses thereof

Country Status (22)

Country Link
EP (1) EP1351698B1 (hu)
JP (1) JP5121038B2 (hu)
KR (1) KR100577498B1 (hu)
CN (1) CN100475233C (hu)
AU (1) AU2002246730B2 (hu)
BG (1) BG66440B1 (hu)
BR (2) BR0116589A (hu)
CA (1) CA2434050C (hu)
DK (1) DK1351698T3 (hu)
ES (1) ES2403240T3 (hu)
HK (1) HK1067072A1 (hu)
HU (1) HUP0303906A3 (hu)
IL (2) IL156543A0 (hu)
MX (1) MXPA03005666A (hu)
NO (1) NO331678B1 (hu)
NZ (1) NZ526995A (hu)
PL (1) PL209402B1 (hu)
RU (1) RU2310466C2 (hu)
SK (1) SK288060B6 (hu)
UA (1) UA80674C2 (hu)
WO (1) WO2002058625A2 (hu)
ZA (1) ZA200305603B (hu)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486464B2 (en) 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition
US20070059358A1 (en) 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof
WO2005049058A1 (fr) * 2003-08-28 2005-06-02 Tianjin Tasly Pharmaceutical Co., Ltd. Radix salviae miltiorrhizae, extrait et composition destines au traitement des maladies de resistance a l'aspirine
CN100442049C (zh) * 2004-03-17 2008-12-10 天津天士力制药股份有限公司 复方丹参滴丸指纹图谱的测定方法
CN100450501C (zh) * 2004-03-17 2009-01-14 天津天士力制药股份有限公司 一种治疗心脑血管疾病的中药制剂及其制备方法
WO2005088295A1 (fr) * 2004-03-17 2005-09-22 Tianjin Tasly Pharmaceutical Co., Ltd. Procede de controle de qualite destine aux pilules a avaler composees de danshen
CN100412546C (zh) * 2004-03-17 2008-08-20 天津天士力制药股份有限公司 一种复方丹参滴丸指纹图谱的测定方法
CN1295505C (zh) * 2004-08-27 2007-01-17 广州中一药业有限公司 胃乃安胶囊的质量控制方法
CN1298340C (zh) * 2004-10-29 2007-02-07 南京生物工程与医药科技发展有限公司 治疗血瘀气滞型心胸痹痛、冠心病心绞痛的中药组合物及其制备方法
CN100390538C (zh) * 2005-06-20 2008-05-28 中国医学科学院药用植物研究所 一种达玛烷型四环三萜皂苷的检测方法
CN101084974B (zh) * 2006-06-08 2011-04-27 天津天士力之骄药业有限公司 一种党参药材的检测方法
CN101078712A (zh) * 2007-04-27 2007-11-28 上海现代中医药技术发展有限公司 扶正化瘀植物药血浆丹参素和丹酚酸b的测定方法
CA2687492C (en) 2007-08-02 2013-08-20 Xiaolin Tong A herbal composition, method for preparing the same and use thereof for treating diabetes mellitus
EP2185167B1 (en) * 2007-09-14 2018-07-04 PHYTO CZ, s.r.o. System and method for assessing traditional medicines
KR20110007473A (ko) * 2009-07-16 2011-01-24 씨제이제일제당 (주) 진세노사이드 강화 분획물을 포함하는 혈압 강하용 조성물
KR101016996B1 (ko) * 2010-06-01 2011-02-28 충남대학교산학협력단 진세노사이드를 함유하는 심혈관계 질환의 예방 및 치료용 조성물
AU2011288044B8 (en) * 2010-08-06 2014-08-07 Tasly Pharmaceutical Group Co., Ltd. Use of Salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease
CN102526380B (zh) * 2010-12-28 2014-02-05 天津同仁堂集团股份有限公司 一种冠脉通片的检测方法
TWI584813B (zh) * 2011-08-22 2017-06-01 Tasly Pharmaceutical Group Co The use of Salvia miltiorrhiza in the preparation of a medicament for secondary prevention of coronary heart disease
CN103033587A (zh) * 2011-09-30 2013-04-10 西安千禾药业有限责任公司 一种用于治疗癫痫抽搐、小儿惊风、面肌痉挛的药物的检测方法
CN102706998A (zh) * 2012-02-15 2012-10-03 江苏苏中药业集团股份有限公司 生脉注射液的质量控制方法
CN102707000B (zh) * 2012-03-14 2015-02-04 周永刚 参仙灵颗粒中人参皂苷Rg1含量的测定方法
CN102526371A (zh) * 2012-03-16 2012-07-04 安徽农业大学 兽用消炎止痛活血消肿药物及其制备方法
CN102768247A (zh) * 2012-04-11 2012-11-07 梁丽 一种治疗冠心病心绞痛药物的检测方法
CN103575819B (zh) * 2012-08-02 2016-08-03 河北以岭医药研究院有限公司 一种强心中药制剂指纹图谱的测定方法
CN103082056B (zh) * 2013-01-04 2015-03-11 云南金七制药有限公司 一种鲜三七液口服液及其制备方法
MX2015017651A (es) 2013-07-11 2016-11-14 Tasly Pharmaceutical Group Co Formulacion de una pildora por goteo y el metodo de preparacion de la misma.
AU2014289763B2 (en) 2013-07-11 2019-03-07 Tasly Pharmaceutical Group Co., Ltd. Traditional chinese medicine composition, and preparation and application thereof
WO2015003662A1 (zh) 2013-07-11 2015-01-15 天士力制药集团股份有限公司 一种中药组合物及其制剂和用途
CN103487548A (zh) * 2013-09-30 2014-01-01 邬建明 一种治疗肝炎的金马肝泰制剂的检测方法
CN103954727A (zh) * 2014-05-15 2014-07-30 山东宏济堂制药集团有限公司 金鸣片的质量控制检测方法
CN105277643B (zh) * 2014-07-17 2018-10-30 天士力医药集团股份有限公司 一种用于复方丹参滴丸的一测多评检测方法
CN108333282A (zh) * 2018-04-24 2018-07-27 山东农业大学 一种同时快速测定复方丹参片中多种酚酸类和丹参酮类成分的方法
CN108752924A (zh) * 2018-06-27 2018-11-06 邱朝转 一种尼龙增强吸附碳粉材料及其制备方法
KR102251247B1 (ko) 2018-08-16 2021-05-12 유상기 협심증 치료용 약학 조성물 및 그 제조방법
CN109507322B (zh) * 2018-12-06 2021-06-04 天津中新药业集团股份有限公司第六中药厂 一种利用指纹图谱对牙痛停滴丸进行质量控制的方法
CN110146623A (zh) * 2019-06-13 2019-08-20 山东孔圣堂制药有限公司 参苓白术丸hplc-elsd指纹图谱的建立方法及其标准图谱
CN112180022B (zh) * 2019-07-03 2023-01-20 江阴天江药业有限公司 一种炒蒺藜或蒺藜中蒺藜皂苷k含量的测定方法
CN111089919B (zh) * 2019-12-29 2022-09-06 贵州景峰注射剂有限公司 一种丹参药物的质量检测方法
CN113125627B (zh) * 2020-01-16 2022-10-18 云南雷允上理想药业有限公司 一种治疗肾病的中药组合物的有效成分检测方法
CN112345683A (zh) * 2020-11-24 2021-02-09 辽宁药联制药有限公司 Lc-ms同时测定血浆中川芎嗪与阿司匹林
CN114646691A (zh) * 2020-12-18 2022-06-21 中国科学院上海药物研究所 一种同时定量大鼠血浆中丹七通脉片15种人参皂苷类成分的分析方法
CN113125596B (zh) * 2021-04-07 2023-01-13 马应龙药业集团股份有限公司 一种高效液相色谱法测定硝酸甘油软膏中有关物质的方法
CN116381124B (zh) * 2023-04-11 2023-08-11 遵义市中医院 一种参芍益气活血颗粒的质量的检测方法及其应用
CN117462593A (zh) * 2023-10-25 2024-01-30 广州白云山和记黄埔中药有限公司 一种组合物在制备预防和/或治疗肺癌引起的心脏病的药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
CN1060399C (zh) * 1993-09-19 2001-01-10 李云峰 护心袋
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression

Also Published As

Publication number Publication date
PL362562A1 (en) 2004-11-02
ES2403240T3 (es) 2013-05-16
BR0116589A (pt) 2003-09-23
DK1351698T3 (da) 2013-04-15
CA2434050A1 (en) 2002-08-01
NZ526995A (en) 2007-02-23
CN100475233C (zh) 2009-04-08
JP2004522952A (ja) 2004-07-29
BG108001A (bg) 2004-11-30
AU2002246730B2 (en) 2006-09-07
IL156543A (en) 2012-07-31
SK9172003A3 (en) 2004-03-02
WO2002058625A3 (en) 2003-03-06
SK288060B6 (sk) 2013-03-01
NO20032893D0 (no) 2003-06-23
MXPA03005666A (es) 2004-12-03
HUP0303906A2 (hu) 2004-05-28
ZA200305603B (en) 2004-04-22
CN1520307A (zh) 2004-08-11
NO20032893L (no) 2003-08-21
BRPI0116589B1 (pt) 2018-07-03
EP1351698A4 (en) 2004-11-03
EP1351698A2 (en) 2003-10-15
CA2434050C (en) 2014-09-16
RU2003123095A (ru) 2005-01-10
UA80674C2 (en) 2007-10-25
BG66440B1 (bg) 2014-08-29
WO2002058625A2 (en) 2002-08-01
JP5121038B2 (ja) 2013-01-16
IL156543A0 (en) 2004-01-04
NO331678B1 (no) 2012-02-20
HK1067072A1 (en) 2005-04-01
KR100577498B1 (ko) 2006-05-10
EP1351698B1 (en) 2013-01-23
KR20030070906A (ko) 2003-09-02
RU2310466C2 (ru) 2007-11-20
PL209402B1 (pl) 2011-08-31

Similar Documents

Publication Publication Date Title
HK1067072A1 (en) Herbal composition for angina pectoris, method to prepare same and uses thereof
AU2002234076A1 (en) Construction composition, structure, and method
EP1347980A4 (en) RECEPTOR SPECIFIC COMPOUNDS OF ADENOSINE-A1, -A2A, AND-A3 AND USES THEREOF
AUPQ879000A0 (en) Mortar composition and method
HUP0302128A3 (en) Anti-dual integrin antibodies, compositions, methods and uses
AU8113701A (en) Anti-il-12 antibodies, compositions, methods and uses
EP1463412A4 (en) COMPOSITION COMPRISING WENGUANGUO EXTRACTS, PREPARATION METHODS AND USES THEREOF
IL152380A0 (en) Improvements to modular buildings, construction elements, methods and materials therefor
AU6832101A (en) Composition and method
AU4163402A (en) Composition and method
EP1342500A4 (en) HYDROGEN PERMEABLE STRUCTURE
AU4215901A (en) Methods and compositions for immunoregulation
AU2001233932A1 (en) Method and composition
EP1409507A4 (en) COMPOSITIONS, METHODS AND KITS RELATING TO REMODELIN
AU2002239775A1 (en) Chemical-library composition and method
AU1182402A (en) Methods and compositions for enhancing angiogenesis
AU7220501A (en) Mortar composition and method
PL347056A1 (en) Novel compounds of heterocycloalkylbezocyclobutane and heterocycloarylbenzocyclobutane, method of obtaining them and pharmacological compositions containming such compounds
EP1272512A4 (en) IMMUNOKIN COMPOSITION AND METHOD
AU2001211674A1 (en) Naphthomelanins, process for their preparation and compositions thereof
HUP0300936A3 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
AU5858101A (en) Materials and methods relating to encapsulation
AU2001297937A1 (en) Herbal composition
AU2001261738A1 (en) Compositions and methods for promoting immunosuppression
TW516468U (en) Improved structure for making and expanding square jar

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD., CN

Free format text: FORMER OWNER(S): TIANJIN TASLY PHARMACEUTICAL CO., LTD., CN; CARDIONAT, INC., US; TIANJIN TASLY PHARMACEUTICAL CO., LTD., CN

MM4A Lapse of definitive patent protection due to non-payment of fees